Skip to main content
    S

    Sunshine Biopharma Inc (SBFM)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $2.60
    -0.10 (-3.70%)

    Market Cap: $2.22M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    33%(4/12)
    Avg Surprise
    -114.04%

    Upcoming Estimates

    Reports Apr 1, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$5.92
    RangeN/A
    3 analysts
    Revenue Consensus
    $10.00M
    Range$9.60M - $10.29M
    3 analysts
    Reports May 11, 2027 (est.)Period ending Mar 31, 2027
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    0 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.11xFCF Yield-875.30%
    Profitability
    Profit Margin-17.40%Operating Margin-16.80%
    ROE-23.40%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio6.47xQuick Ratio4.03x
    Trading Statistics
    Beta1.52Avg Volume462.85K
    52-Week High$464.0052-Week Low$2.53

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 73.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 28.2, below 30, the oversold line.

    Moving Averages

    SMA 10$2.74
    SMA 20$3.01
    SMA 50$9.65
    SMA 200$95.54
    EMA 10$2.84
    EMA 20$3.83
    EMA 50$10.40
    EMA 200$85.54

    MACD

    Line: -1.84Signal: -2.36Hist: 0.52

    ADX

    ADX: 54.2+DI: 3.4-DI: 0.9

    Aroon & PSAR

    Aroon Up52.0
    Aroon Down36.0
    PSAR$2.01

    Bollinger Bands

    Upper Band$4.02
    Lower Band$2.00
    %B Position6711%(Upper)
    Band Width0.30

    RSI (14-Day)

    Oversold
    28.2

    Momentum Oscillators

    Stoch %K20.1
    Stoch %D43.0
    Williams %R-92.3
    ROC (10d)-5.5%
    Momentum-0.15
    CCI (20d)10.9
    MFI (14d)68.9

    Volatility Measures

    ATR (14d)$3.25(125.0%)
    StdDev (20d)0.50
    Hist Vol126.1%(High)

    Volume Flow

    VWAP$2.61
    OBV697.8M
    AD Line1152.7B
    CMF (20d)155.587

    Volume Metrics

    Avg Vol (20d)422.2K
    Vol Ratio0.1x(Low)
    VWMA (20d)$3.28

    Pivot Points

    R3$2.88
    R2$2.83
    R1$2.76
    Pivot Point$2.71
    S1$2.65
    S2$2.60
    S3$2.53

    Advanced Oscillators

    TSI-44.52
    Ultimate Osc51.8
    KST-564.48

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about SBFM

    News

    SBFM Valuation

    P/FCF
    -0.1x
    P/B
    0.0x
    All SBFM metrics

    SBFM Profitability: Margins, ROIC and FCF

    Sunshine Biopharma (SBFM) has a gross margin of 30.4%, an operating margin of -16.8% and a net margin of -17.4%. It posts a -15.1% FCF margin.

    Gross margin
    30.4%
    Operating margin
    -16.8%
    Net margin
    -17.4%
    ROE
    -23.4%
    FCF margin
    -15.1%
    FCF yield
    -875.3%
    SBFM financial statements

    Sunshine Biopharma Competitors

    The companies most similar to Sunshine Biopharma (SBFM) include Redhill Biopharma, PRF Technologies and cbdMD.

    Sector: Healthcare

    Companies most similar to Sunshine Biopharma

    SBFM Bull Case vs Bear Case

    Bear case

    • SBFM has a -17.4% net profit margin.
    • SBFM beat EPS estimates in 25.0% of its last 8 reported quarters.

    SBFM Earnings: Beat Rate and Next Report

    Sunshine Biopharma (SBFM) beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate (25.0%). Its next report is expected on Apr 1, 2027.

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -164.7%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$5.92
    SBFM earnings history

    SBFM Earnings Date

    SBFM reports Apr 1, 2027. The date is estimated.

    Updated Nov 12, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About SBFM

    When does SBFM report earnings?

    Sunshine Biopharma Inc (SBFM) is expected to report earnings on Apr 1, 2027.

    Does SBFM pay dividends?

    Sunshine Biopharma Inc (SBFM) does not currently pay a regular dividend.

    What is SBFM's market cap?

    Sunshine Biopharma Inc (SBFM) has a market capitalization of $2.22M with a current stock price of $2.60.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.